https://www.nature.com/articles/s41420-024-01815-9 [2]Liu F,et al.Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future? Front Oncol. 2024 May 28;14:1390006. https://www.ncbi....
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02462-0/abstract [2]Huang R,et al.Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phas...
参考文献: 1.Exploring the NK cell platform for cancer immunotherapy. Nat RevClin Oncol. 2020 Sep 15. 2. K Cell-Based Immune Checkpoint Inhibition. Front. Immunol., 13February 2020 3. CAR-expressing NK cells for cancer therapy: a new hope. BiosciTrends. 2020 Sep 6. 4. Chimeric antigen ...
[3]Li C,et al.Robo1-specific chimeric antigen receptor natural killer cell therapy for pancreatic ductal adenocarcinoma with liver linkstasis[J].Journal of Cancer Research and Therapeutics,2020, 16(2): 393-396.https://journals.lww.com/cancerjournal/fulltext/2020/16020/robo1_specific_chimeric_a...
CANCER treatmentCHIMERIC antigen receptorsLung cancer remains one of the leading causes of cancer-related mortality worldwide necessitating the development of innovative therapeutic strategies. Chimeric antigen receptor (CAR) natural killer (NK) cell therapy represents a promising ...
最近，针对应用NK细胞治疗癌症的研究综述《NK Cell Therapy: A Rising Star in Cancer Treatment》发表于国际肿瘤核心期刊《Cancers》[2]。研究发现，癌症组织中的 NK 细胞数量低于正常水平，这种情况下有助于癌细胞的生长。此外，NK细胞的免疫功能受损，也会干扰抗癌免疫。因此，正在进行许多研究以开发基于增加 NK ...
1、Case Report: Feasibility and Safety of Autologous NK Cell Therapy in Patients with Cancer https://www.scirp.org/journal/paperinformation.aspx?paperid=114179 2、Graft-versus-host disease https://www.sciencedirect.com/science/article/pii/S0140673609602373?via%3Dihub 3、2016年中国恶心肿瘤流行情况...
今天，在肿瘤防治宣传周之际，我们通过《Cancer Immunity and Immunotherapy 》杂志发表的NK细胞治疗晚期肝细胞癌的I期临床实验研究结果 [1]，带大家认识免疫细胞治疗肝癌。11名晚期肝癌患者接受NK细胞治疗 这项研究涉及的时间范围为2016年3月至2021年6月，共有11名局部晚期肝细胞癌（HCC）患者接受肝动脉灌注化疗（HA...
3. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report - PMC (nih.gov)4. Investigation of the efficacy and feasibility of combined therapy of PD 1﹏hanced exogenous peripatetic adoptive natural killer (NK) cells in combination with antiangiogenic targeted therapy ...
Tarannum M, Romee R. Cytokine-induced memory-like natural killer cells for cancer immunotherapy. Stem Cell Res Ther. 2021 Dec 4;12(1):592. Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. ...